These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3728117)

  • 21. Triamterene stones and computerized axial tomography.
    Guevara A; Springmann KE; Drach GW; Hillman BJ
    Urology; 1986 Feb; 27(2):104-6. PubMed ID: 3946031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triamterene and renal stones.
    Jick H; Dinan BJ; Hunter JR
    J Urol; 1982 Feb; 127(2):224-5. PubMed ID: 7062371
    [No Abstract]   [Full Text] [Related]  

  • 23. Does triamterene cause renal calculi?
    Woolfson RG; Mansell MA
    BMJ; 1991 Nov; 303(6812):1217-8. PubMed ID: 1747638
    [No Abstract]   [Full Text] [Related]  

  • 24. [Renal lithiasis medicamentosa].
    Traba ML; Rapado A; Bonet F; Cifuentes Delatte L
    Med Clin (Barc); 1984 Nov; 83(14):607-8. PubMed ID: 6513652
    [No Abstract]   [Full Text] [Related]  

  • 25. Triamterene stone: advantage of crystallographic analysis.
    Watson RA; Ettinger B; Deshon GE; Agee RE; Oldroyd NO
    Urology; 1981 Sep; 18(3):238-40. PubMed ID: 6269267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Triamterene induced nephrolithiasis (author's transl)].
    Lucas C; Cukier J; Daudon M; Protat MF; Reveillaud RJ
    J Urol (Paris); 1982; 88(1):37-42. PubMed ID: 7037980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excretion of triamterene and its metabolite in triamterene stone patients.
    Ettinger B
    J Clin Pharmacol; 1985; 25(5):365-8. PubMed ID: 4031113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced renal stones: incidence, clinical expression and stone analysis.
    Rapado A; Traba ML; Caycho C; Cifuentes-Delatte L
    Contrib Nephrol; 1987; 58():25-9. PubMed ID: 2826078
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pancytopenia induced by triamterene: 4 cases].
    Buffet C; Chaput JC; Labayle D; Etienne JP
    Gastroenterol Clin Biol; 1981 Dec; 5(12):1197-8. PubMed ID: 7319216
    [No Abstract]   [Full Text] [Related]  

  • 30. Triamterene-induced crystalluria and cylinduria: clinical and experimental studies.
    Fairley KF; Woo KT; Birch DF; Leaker BR; Ratnaike S
    Clin Nephrol; 1986 Oct; 26(4):169-73. PubMed ID: 3780069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute kidney failure caused by triamterene and hydrochlorothiazide].
    Heitmann D; Rumpf KW; Scheler F
    Dtsch Med Wochenschr; 1982 May; 107(21):836. PubMed ID: 7075507
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of zinc in nephrolithiasis.
    Gupta A; Srivastava DK; Kumar S
    J Indian Med Assoc; 1984 Jul; 82(7):235-7. PubMed ID: 6545899
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic findings in patients with urate nephrolithiasis].
    Revúsová V; Gratzlová J; Valovicová E; Krídl J
    Vnitr Lek; 1973 Aug; 19(8):744-9. PubMed ID: 4731150
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nephrolithiasis induced by hyperparathyroidism].
    Marković V; Macura D
    Srp Arh Celok Lek; 1974 Feb; 102(2):101-10. PubMed ID: 4410206
    [No Abstract]   [Full Text] [Related]  

  • 36. [Significance of mucopolysaccharide structural changes in the pathogenesis and diagnosis of nephrolithiasis].
    Borisova-Khromenko VM; Berezin IuV; Maletin AG; Neĭmark AI
    Urol Nefrol (Mosk); 1981; (1):18-20. PubMed ID: 6451975
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage].
    Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1995; (2):21-2. PubMed ID: 7785114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-obstructive nephrolithiasis: metabolic and immunopathological studies.
    Jeantet A; Tetta C; Camussi G; Ferrando U; Rotunno M; Thea A; Gaido M; Vercellone A
    Contrib Nephrol; 1985; 49():123-7. PubMed ID: 3913569
    [No Abstract]   [Full Text] [Related]  

  • 39. Exacerbation of nephrolithiasis by a carbonic anhydrase inhibitor.
    Wallace MR; MacDiarmid J; Reeder J
    N Z Med J; 1974 Feb; 79(509):687-90. PubMed ID: 4522951
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of calcium, oxalate and inhibitory activity of the urine in patients with calcium nephrolithiasis].
    Han KH; Cao LC; Ying YL
    Zhonghua Wai Ke Za Zhi; 1986 Mar; 24(3):173-5, 190. PubMed ID: 3757655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.